C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/30/2004	US6825320 For diagnosis/prevention/treatment of tumors/cancer
11/30/2004	US6825319 Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome
11/30/2004	US6825318 Vaccine for obesity therapy; hybrid polypeptides
11/30/2004	US6825168 Antithrombin protein and DNA sequences from black fly
11/30/2004	US6825167 Targeting moiety facilitates the interaction and/or binding of the linked antiangiogenic moiety to endothelial cells
11/30/2004	US6825166 Molecular conjugates for use in treatment of cancer
11/30/2004	US6825165 Betacellulin modification
11/30/2004	US6825164 Method to increase cerebral blood flow in amyloid angiopathy
11/30/2004	US6825038 Method for generating hypermutable organisms
11/30/2004	US6825037 Recombinant transferrins, transferrin half-molecules and mutants thereof
11/30/2004	US6825035 For drug screening; gene knockout; genetic engineering
11/30/2004	US6825034 Human RRN3 and compositions and methods relating thereto
11/30/2004	US6825030 Nucleotide sequences coding enzymatic polypeptide for use in generation of lysine for foods, medicines and animal nutrients
11/30/2004	US6825023 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
11/30/2004	US6825013 Isolation of biosynthesis genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O, and their use
11/30/2004	US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004	US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004	US6825006 Preparing an insect-resistant plant, genetic engineered insecticides, crystal protein from culturing the cells, encoding endotoxins having insecticidal activity
11/30/2004	US6825005 Methods and reagents to regulate apoptosis
11/30/2004	US6824995 For detecting muc18 glycoprotein using blot analysis/polymerase chain reaction (pcr) on biopsy tissue
11/30/2004	US6824994 Peptide ligands that mimic sensor kinases and inhibit response regulators
11/30/2004	US6824993 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
11/30/2004	US6824991 Human bad polypeptides, encoding nucleic acids and methods of use
11/30/2004	US6824990 Methods of detecting and modulating oligomerization of G protein-coupled receptors
11/30/2004	US6824984 For food/health care/military use; solid phase synthesis; kits
11/30/2004	US6824979 Catabolite repression control (Crc) gene and Pseudomonas virulence
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	US6824976 Method for selective inactivation of viral replication
11/30/2004	US6824973 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders
11/30/2004	US6824784 Cold-adapted equine influenza viruses
11/30/2004	US6824783 Delaying the onset of aids in an hiv- 1 infected individual, comprising administering a peptide which inhibits membrane fusion-associated events, i.e. syncytia formation between hiv-1 infected cells and cells uninfected
11/30/2004	US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
11/30/2004	US6824781 Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist
11/30/2004	US6824780 Anti-tumor antibody compositions and methods of use
11/30/2004	US6824779 Methods for inhibiting the interaction of B7-2 with its natural ligand
11/30/2004	US6824777 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
11/30/2004	US6824776 Forming metalprotein biocomposite and sol containing catalyst and silicon alkoxide; mixing to produce gel; extracting and supercritically drying with carbon dioxide
11/30/2004	US6824775 88kDa tumorigenic growth factor and antagonists
11/30/2004	US6824774 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination
11/30/2004	US6824773 TWEAK receptor
11/30/2004	US6824770 Adenovirus gene expression system
11/30/2004	US6824767 Nuclelotide sequences coding polypeptide for use in the treatment of tumors, cachexia, septic shock, brain disorders, inflammation, arthritis and immunological defects
11/30/2004	US6824659 Mutant staphylococcal alpha hemolysin polypeptide containing heterologous analyte binding amino acid
11/30/2004	CA2430586A1 Population profiling materials and methods
11/30/2004	CA2239099C Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
11/30/2004	CA2238439C Method for preparation of type ii collagen
11/30/2004	CA2147006C Method for increasing expression and reducing expression variability of foreign genes in plant cells
11/30/2004	CA2144081C Protection against liver damage by hgf
11/30/2004	CA2136087C Sequence of human dopamine transporter cdna
11/30/2004	CA2072350C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
11/25/2004	WO2004102195A1 Method for identifying tff2 regulating agents and agents identified using said method
11/25/2004	WO2004101826A2 Methods to identify compounds that modulate the autoinducer-2 dependent quorum sensing system in vibrio harveyi
11/25/2004	WO2004101818A1 Detecting method of the schizophrenia susceptible gene and use
11/25/2004	WO2004101799A2 Broadening adenovirus tropism
11/25/2004	WO2004101798A2 Method for the preparation of transgenic plants characterised by geminivirus lasting resistance
11/25/2004	WO2004101797A1 Process of producing a plastid-targeted protein in plant cells
11/25/2004	WO2004101795A1 Variable proteins of mycoplasma mycoides, vaccines and process thereof
11/25/2004	WO2004101792A1 Flowering inhibition
11/25/2004	WO2004101791A1 Flowering induction
11/25/2004	WO2004101789A1 Cardiotonic polypeptides
11/25/2004	WO2004101781A1 Crystal structure of human coronavirus 229e main proteinase, and uses thereof for developing sars inhibitors
11/25/2004	WO2004101768A2 Recombinant comamonas testosreroni 5-mgam-4d amids and carboxylic acid production
11/25/2004	WO2004101766A2 Grp94-based compositions and methods of use thereof
11/25/2004	WO2004101747A2 Identification and use of gpr54 and its ligands for reproductive disorders and contraception
11/25/2004	WO2004101741A2 Transgenic plants with increased glycine-betaine
11/25/2004	WO2004101739A2 Methods for chemically synthesizing immunoglobulin chimeric proteins
11/25/2004	WO2004101620A2 Serum albumin scaffold-based proteins and uses thereof
11/25/2004	WO2004101618A2 Progestin-yol002c-cgi-45 receptor-related proteins
11/25/2004	WO2004101617A1 Active variants of the il-18 binding protein and medical uses thereof
11/25/2004	WO2004101616A1 LIVER X RECEPTOR α SPLICING MUTANT PROTEIN, GENE THEREOF AND UTILIZATION OF THE SAME
11/25/2004	WO2004101615A2 Secreted polypeptide species associated with cardiovascular disorders
11/25/2004	WO2004101614A1 Promoter sequences from hevea brasiliensis hevein genes
11/25/2004	WO2004101612A2 Thioredoxin-peroxidase of c. albicans as a virulence-specific marker
11/25/2004	WO2004101611A2 Peptides that bind to the erythropoietin receptor
11/25/2004	WO2004101610A1 Oligopeptide
11/25/2004	WO2004101608A2 Apo2l (trail) receptor binding peptides and uses thereof
11/25/2004	WO2004101607A2 Comparative ligand mapping from mhc class i positive cells
11/25/2004	WO2004101606A2 Novel peptides that bind to the erythropoietin receptor
11/25/2004	WO2004101600A2 Novel poly(ethylene glycol) modified compounds and uses thereof
11/25/2004	WO2004100997A2 Spacer moiety for poly(ethylene glycol) -modified peptides
11/25/2004	WO2004100987A2 Methods of using il-1 antagonists to treat neointimal hyperplasia
11/25/2004	WO2004100985A2 Materials and methods for immunizing against fiv infection
11/25/2004	WO2004100898A2 Therapeutic use of anti-cs1 antibodies
11/25/2004	WO2004100886A2 POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY
11/25/2004	WO2004100877A2 Vaccine accelerator factor (vaf) for poultry
11/25/2004	WO2004100870A2 Compositions and methods for wt1 specific immunotherapy
11/25/2004	WO2004100861A2 Pharmaceutical composition comprising lectin
11/25/2004	WO2004100774A2 Receptors and membrane-associated proteins
11/25/2004	WO2004100659A2 Dinoflagellate karlotoxins, methods of isolation and uses thereof
11/25/2004	WO2004093898A3 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/25/2004	WO2004093662A3 Method for detecting prognosis of cancer
11/25/2004	WO2004090142A3 Plants having modified growth characteristics and method for making the same
11/25/2004	WO2004088307A3 Detection method for the expression of recombinant proteins on a cell surface and for the immobilization and purification of cells and proteins
11/25/2004	WO2004087747A3 Citrullinated synthetic peptides and uses thereof
11/25/2004	WO2004085479A3 Treatment of viral infections
11/25/2004	WO2004085468A3 Human p53 splice variant displaying differential transcriptional activity
11/25/2004	WO2004084965A3 Improved osteoinductive materials
11/25/2004	WO2004078203A3 Infectious bronchitis virus with an altered spike gene
11/25/2004	WO2004078123A3 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
11/25/2004	WO2004074315A3 Analogues of glp-1

1 ... 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 ... 2916